Laxacin

Manufacturer
medsource pharmaceuticals
Effective date
2018-12-20
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 00:40:09

Label at a glance#

ProductLaxacin
Active ingredientDOCUSATE SODIUM, SENNOSIDES A AND B
Label structure8 sections

Indications and uses

relieves occasional constipation (irregularity) generally produces a bowel movement in 6-12 hours

Dosage and administration

take preferably at bedtime or as directly by a doctor age starting dose maximum dose adults and children 12 years and older 2 tablets once a day 4 tablets twice a day Other information Each tablet contains: Calcium 20 mg Each tablet contains: Sodium 4 mg Store at room temperature Keep lid tightly closed in a dry place Do not use if imprinted safety seal under cap is broken or missing

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Docusate Sodium 50 mg

Sennosides 8.6 mg

Purpose

OTC - PURPOSE SECTION

Stool Softener

Laxative

Uses

INDICATIONS & USAGE SECTION

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement in 6-12 hours

Warnings

WARNINGS SECTION

Do not use

  • if you are now taking mineral oil, unless directed by a doctor
  • laxative products for longer than 1 week unless directed by a doctor

 

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative.
These may indicate a serious condition.

If pregnant or breast feeding, ask a health professional before use.

Keep Out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

LOT#

Exp. Date:

Directions

DOSAGE & ADMINISTRATION SECTION

  • take preferably at bedtime or as directly by a doctor
agestarting dosemaximum dose
adults and children 12 years and older2 tablets once a day4 tablets twice a day

Other information

  • Each tablet contains: Calcium 20 mg
  • Each tablet contains: Sodium 4 mg
  • Store at room temperature
  • Keep lid tightly closed in a dry place
  • Do not use if imprinted safety seal under cap is broken or missing

Inactive ingredients

INACTIVE INGREDIENT SECTION

Croscarmellose Sodium, D&C Yellow #10, Dextrose, Dicalcium Phosphate, FD&C Yellow #6, Hypromelose, Magnesium Stearate, Microcrystalline Cellulose, Polyethylene Glycol, Silica, Sodium Benzoate, Stearic Acid, Titanium Dioxide.

Questions? If you have any questions or comments, or to report an adverse event, please contact (480) 253-9761.

Manufactured for:
Alexso Inc.
Thousand Oaks, CA 91360

Package/Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

pdppdp

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50488-0901-1EA - Each50488-0901933d71c3-b01d-44ff-b256-0bee20827ae812012-07-24

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
45865-70845865-708-60
50488-0901

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LaxacinDOCUSATE SODIUM AND SENNOSIDESAlexso, Inc0df9abaf-3997-4dde-8003-ae3d8d07cf392024-12-04WarningsExact identifier
ndc (product): 50488-0901
7d77bb0b-6554-904d-e053-2a91aa0a55437d77cad2-b2b1-c909-e053-2a91aa0a04732018-12-20WarningsExact identifier
spl id: 7d77bb0b-6554-904d-e053-2a91aa0a5543
spl set id: 7d77cad2-b2b1-c909-e053-2a91aa0a0473

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.